Victory Capital Management Inc. Has $57.76 Million Position in Encompass Health Corporation (NYSE:EHC)

Victory Capital Management Inc. grew its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 8.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 570,306 shares of the company's stock after purchasing an additional 42,245 shares during the quarter. Victory Capital Management Inc. owned about 0.57% of Encompass Health worth $57,761,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. HighTower Advisors LLC boosted its holdings in shares of Encompass Health by 10.3% during the 4th quarter. HighTower Advisors LLC now owns 18,955 shares of the company's stock valued at $1,751,000 after buying an additional 1,764 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in Encompass Health by 21.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 2,555 shares of the company's stock worth $236,000 after acquiring an additional 451 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in Encompass Health by 8.2% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 9,488 shares of the company's stock valued at $876,000 after acquiring an additional 716 shares during the period. Signaturefd LLC lifted its holdings in Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the period. Finally, Intech Investment Management LLC raised its position in Encompass Health by 31.0% during the fourth quarter. Intech Investment Management LLC now owns 17,514 shares of the company's stock worth $1,617,000 after acquiring an additional 4,143 shares during the period. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

NYSE EHC traded up $0.13 on Monday, hitting $110.14. 254,935 shares of the stock traded hands, compared to its average volume of 731,449. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a 12 month low of $82.74 and a 12 month high of $123.13. The firm has a market capitalization of $11.10 billion, a price-to-earnings ratio of 22.77, a PEG ratio of 2.23 and a beta of 0.88. The business's fifty day moving average is $119.05 and its two-hundred day moving average is $107.02.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The firm's quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.12 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.62%. Encompass Health's dividend payout ratio is currently 14.05%.

Insider Transactions at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president directly owned 79,710 shares of the company's stock, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider owned 11,958 shares in the company, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock valued at $16,034,082 in the last ninety days. Corporate insiders own 2.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on EHC. Truist Financial restated a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Royal Bank Of Canada upped their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Barclays upped their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Finally, Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $131.50.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.